Medical device company Gardia Medical Ltd. was the second life sciences company to withdraw its IPO on the Tel Aviv Stock Exchange (TASE) yesterday, citing market conditions. The announced came shortly after Trig Medical Ltd. pulled its IPO, citing the same reason. Gardia planned to raise NIS 30 million at a company value of NIS 100 million, after money.
Gardia Medical's Embolic Protection System, a catheter-based delivery system that integrates with the standard stents and other cardiovascular interventional procedures to prevent embolism.
Gardia said that it will try again to hold the IPO in the second quarter.
Life sciences IPOs on the TASE so far this year have been mixed. RedHill Biopharma Ltd. (TASE: RDHL), IceCure Ltd. (TASE: ICCM), Rosetta Green Ltd. (TASE: RSTG), and Glycominds Ltd. (TASE: GLCM) have succeeded. The offerings of RedHill and Glycominds were both oversubscribed, but IceCure barely succeeded, and Rosetta Green's offering only passed muster thanks to purchases by the underwriters.
Published by Globes [online], Israel business news - www.globes-online.com - on March 8, 2011
© Copyright of Globes Publisher Itonut (1983) Ltd. 2011